These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 703988

  • 1. Elevated serum cathepsin B1 and vaginal pathology after prenatal DES exposure.
    Pietras RJ, Szego CM, Mangan CE, Seeler BJ, Burtnett MM, Orevi M.
    Obstet Gynecol; 1978 Sep; 52(3):321-7. PubMed ID: 703988
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Congenital diethylstilbestrol-associated vaginal/cervical adenosis (DES babies).
    Barclay DL.
    J Ark Med Soc; 1979 May; 75(12):451-2. PubMed ID: 156173
    [Abstract] [Full Text] [Related]

  • 4. Prenatal diethylstilbestrol (DES) exposure. Recommendations of the Diethylstilbestrol-Adenosis (DESAD) Project for the identification and management of exposed individuals.
    Clin Pediatr (Phila); 1983 Feb; 22(2):139-43. PubMed ID: 6822019
    [Abstract] [Full Text] [Related]

  • 5. The current status of the DES-exposed population.
    Herbst AL.
    Obstet Gynecol Annu; 1981 Feb; 10():267-78. PubMed ID: 7024873
    [Abstract] [Full Text] [Related]

  • 6. Vaginal adenosis and adenocarcinoma in mice exposed prenatally or neonatally to diethylstilbestrol.
    Newbold RR, McLachlan JA.
    Cancer Res; 1982 May; 42(5):2003-11. PubMed ID: 7066910
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Symposium on Adolescent Gynecology and Endocrinology. Part II: Secondary amenorrhea, hirsutism in adolescents and the clinical consequences of stilbestrol exposure in utero. The clinical consequences of stilbestrol exposure in utero.
    Kurman RJ.
    West J Med; 1979 Dec; 131(6):526-32. PubMed ID: 545869
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Influence of in utero diethylstilbestrol exposure on the prognosis and biologic behavior of vaginal clear-cell adenocarcinoma.
    Waggoner SE, Mittendorf R, Biney N, Anderson D, Herbst AL.
    Gynecol Oncol; 1994 Nov; 55(2):238-44. PubMed ID: 7959291
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Genital clear cell adenocarcinoma.
    Johnston GA, Jones HA.
    Int Surg; 1983 Nov; 68(3):257-61. PubMed ID: 6662641
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clear cell carcinoma of the cervix and vagina in young women. A report of six cases with association of maternal stilbestrol therapy and adenosis of the vagina.
    Hill EC.
    Trans Pac Coast Obstet Gynecol Soc; 1972 Nov; 40():15-29. PubMed ID: 4668177
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.